The U.S. is facing another recall of Enfamil Infant Formula. Their Nutramigen Hypoallergenic Infant Formula Powder in 12.6 and 19.8oz cans, a specialized powdered baby formula for infants with cow's milk allergies, has been recalled due to potential bacterial contamination. This is the the second recall by Reckitt/Mead Johnson Nutrition within a year, and follows a major formula shortage two years ago that prompted concerns about industry oversight.
As of December 31st, the FDA reported no reported illnesses linked to the current recall, stating that most of the distributed product in the U.S. may have already been consumed. The recall involves 675,030 cans of Nutramigen powdered formula and was initiated after the Israeli Ministry of Health informed the FDA that batches exported from the U.S. had initially tested positive for Cronobacter species during routine sampling. Cronobacter can lead to severe infections, including cronobacter sakazakii, posing significant risks, especially to newborns with immature immune systems.
The 2022 shortage, mainly attributed to pandemic-related supply chain strains, panic buying, and a factory shutdown in Michigan over Cronobacter concerns, prompted the FDA to take various measures to enhance formula safety. These measures include the development of a Cronobacter prevention strategy, increased inspections, regulatory actions, and calls for information sharing among those involved in manufacturing and distributing powdered infant formula.
The FDA reassures the public that this recall is not expected to have a major impact on the U.S. supply and availability of powdered infant formulas.